Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ARPA-H
Biotech
ARPA-H goes all in on in vivo cell therapy
One of the grant winners is a newly emerged biotech called ImmunoVec, which debuted with up to $40.7 million in funding from ARPA-H.
Darren Incorvaia
Oct 8, 2025 4:04pm
ARPA-H invests in Kernal's mRNA cell therapy
Oct 7, 2025 3:20pm
ARPA-H unveils programs to develop custom gene editing therapies
Sep 26, 2025 10:41am
Pfizer vet lands first CEO role—Chutes & Ladders
Aug 15, 2025 8:30am
ARPA-H data chief departs over mRNA vax cancellations
Aug 12, 2025 12:15pm
'Too big and unfocused': Trump slashes NIH budget by $18B
May 2, 2025 2:42pm
